Cambridge Investment Research Advisors’s iShares Core MSCI International Developed Markets ETF IDEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.5M Buy
387,981
+16,081
+4% +$1.43M 0.08% 262
2026
Q1
$31.1M Buy
371,900
+47,005
+14% +$4.04M 0.08% 248
2025
Q4
$26.8M Sell
324,895
-127,917
-28% -$10.4M 0.07% 267
2025
Q3
$36.3M Buy
452,812
+22,026
+5% +$1.71M 0.1% 197
2025
Q2
$32.8M Buy
430,786
+26,315
+7% +$1.9M 0.1% 199
2025
Q1
$27.9M Buy
404,471
+19,167
+5% +$1.31M 0.09% 218
2024
Q4
$24.8M Buy
385,304
+23,760
+7% +$1.6M 0.08% 231
2024
Q3
$25.6M Buy
361,544
+111,904
+45% +$7.59M 0.09% 225
2024
Q2
$16.4M Buy
249,640
+59,632
+31% +$3.97M 0.06% 320
2024
Q1
$12.8M Buy
190,008
+32,403
+21% +$2.09M 0.05% 370
2023
Q4
$10M Buy
157,605
+14,242
+10% +$849K 0.04% 405
2023
Q3
$8.36M Buy
143,363
+28,243
+25% +$1.71M 0.04% 435
2023
Q2
$7.04M Buy
115,120
+18,157
+19% +$1.11M 0.03% 503
2023
Q1
$5.86M Sell
96,963
-8,860
-8% -$526K 0.03% 558
2022
Q4
$5.92M Buy
105,823
+17,098
+19% +$919K 0.03% 533
2022
Q3
$4.29M Buy
88,725
+17,889
+25% +$962K 0.02% 637
2022
Q2
$3.81M Buy
70,836
+9,098
+15% +$535K 0.02% 718
2022
Q1
$3.93M Buy
61,738
+14,134
+30% +$910K 0.02% 755
2021
Q4
$3.22M Buy
47,604
+559
+1% +$38K 0.01% 880
2021
Q3
$3.14M Sell
47,045
-1,060
-2% -$72.5K 0.02% 845
2021
Q2
$3.25M Buy
48,105
+14,966
+45% +$1.01M 0.02% 851
2021
Q1
$2.14M Buy
33,139
+349
+1% +$22.3K 0.01% 970
2020
Q4
$2.02M Buy
32,790
+7,726
+31% +$447K 0.01% 916
2020
Q3
$1.35M Buy
25,064
+8,764
+54% +$473K 0.01% 1012
2020
Q2
$833K Buy
16,300
+1,392
+9% +$67.4K 0.01% 1230
2020
Q1
$661K Buy
14,908
+3,184
+27% +$169K 0.01% 1209
2019
Q4
$682K Buy
11,724
+1,513
+15% +$85.7K 0.01% 1374
2019
Q3
$558K Buy
10,211
+460
+5% +$24.8K ﹤0.01% 1428
2019
Q2
$534K Buy
9,751
+3,435
+54% +$188K ﹤0.01% 1380
2019
Q1
$342K Buy
+6,316
New +$332K ﹤0.01% 1729

Other funds holding IDEV

Cambridge Investment Research Advisors's IDEV Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its iShares Core MSCI International Developed Markets ETF (IDEV) stake by 4.3% in Q2 2026, buying an estimated $1.43M and bringing the position to 387,981 shares worth $34.5M. The position accounts for 0.08% of the portfolio, ranked #262.

Cambridge Investment Research Advisors first reported a position in IDEV in Q1 2019 and has held it in 30 quarters since. The position peaked at $36.3M in Q3 2025. 738 funds tracked by Wall St. Rank hold IDEV as of Q2 2026.

  • Cambridge Investment Research Advisors held 387,981 shares of iShares Core MSCI International Developed Markets ETF worth $34.5M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 16,081 iShares Core MSCI International Developed Markets ETF shares in Q2 2026, an estimated $1.43M.
  • iShares Core MSCI International Developed Markets ETF made up 0.08% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #262 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares Core MSCI International Developed Markets ETF in Q1 2019 and has held it in 30 quarters since.
  • Cambridge Investment Research Advisors's iShares Core MSCI International Developed Markets ETF position peaked at $36.3M in Q3 2025.
  • 738 funds tracked by Wall St. Rank held iShares Core MSCI International Developed Markets ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.